Prosthetics and Orthotics Market Size, Share, Growth, Report 2025 to 2034

Prosthetics and Orthotics Market Size and Growth 2025 to 2034

The global prosthetics and orthotics market size was reached at USD 6.45 billion in 2024 and is expected to be worth around USD 9.82 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.7% over the forecast period from 2025 to 2034.

The prosthetics and orthotics market focuses on the design and production of advanced medical devices that restore mobility and function for individuals with limb loss or musculoskeletal conditions. Driven by rising incidences of diabetes, trauma, and vascular diseases, the market benefits from innovations like 3D printing, smart sensors, and AI-powered adaptive prosthetics that offer improved comfort and functionality. Collaborations between device manufacturers and tech companies are accelerating the development of personalized, lightweight, and intelligent solutions, while regulatory support and increasing awareness boost adoption. Integration with digital health and tele-rehabilitation platforms is further enhancing patient care, making prosthetics and orthotics more accessible, responsive, and effective in improving quality of life.

Prosthetics and Orthotics Market Report Highlights

• By Region, North America led the region accounting with 41% of the market share in 2024.
• By Technology, the electric-powered prosthetics segment holds major share of around 43% in 2024.
• By Type, the orthotic devices segment holds major share of around 60% and is likely to remain same throughout the forecast period
• By End-user, the hospitals segment account major share of 35% in the 2024.

Prosthetics and Orthotics Market Growth Factors

• Rising Incidence of Chronic Conditions: The rising number of chronic conditions such as diabetes and heart disease is a significant driver of growth for the prosthetics and orthotics market. The World Health Organization (WHO) has reported that more than 422 million people worldwide have diabetes, which greatly increases the chances of limb amputations due to complications such as diabetic foot ulcers. This leads to a growing incidence of demand for prosthetic limbs, as well as orthotic devices that help restore the ability to walk and function autonomously. For example, the U.S. Centers for Disease Control and Prevention (CDC) has reported an upward trend in the number of amputations due to diabetes which demonstrates the ongoing need for prosthetic care. In addition, governments around the world are increasing funding for rehabilitation to deal with diabetes, which will in turn increase funding for prosthetic markets.
• Technological Advances: As technology continues to develop, it has significantly driven the prosthetics and orthotics market forward by enhancing functionality and usability. More advanced materials, such as carbon fiber and titanium, have improved strength and durability while bringing down the weight of the devices. The advent of 3D printing has also been a very positive step because clients can now create highly customized devices, and delivery times are dramatically decreased. The Federal Drug Administrative (FDA) has approved smart prosthetics using artificial intelligence (AI), which suggests that the public is growing more accepting of advanced technology in prosthetics. These innovations allow for better fitting, adaptive movement, and increased user satisfaction, driving higher adoption rates worldwide. Continued investment in research supported by government grants accelerates product development and market expansion.
• Aging Population: The worldwide increase in elderly population is related to the need for prosthetics and orthotics. The United Nations reports that there will be 1.6 billion people aged 65 and over by 2050 and many are likely to have mobility restrictions due to conditions such as osteoarthritis which may subsequently require orthotic support. This trend of aging population is seen most strongly across the developed world (e.g., North America, Europe, and Japan) as healthcare systems adapt to an aging society. For example, Medicare is now covering more prosthetic and orthotic devices through public health programs which make devices available to seniors. Manufacturers increasingly respond by producing devices that are user-friendly, supportive, and are designed with comfort in mind specific to older adults needs thereby improving their footprint and reach into the market.

Prosthetics and Orthotics Market Trends

• Personalization and Customization: Personalization and customization are now the norm for prosthetic and orthotic devices, specifically due to advances in 3D scanning and printing methodology. Not only do customized devices typically yield better fitting and improved comfort, but ultimately leading to improved patient compliance, and outcomes. Regulatory agencies, specifically the United States Food and Drug Administration (FDA), have developed guidelines and framework to ensure that personalized medical devices are generally safe and effective, and this has helped to spur innovation. This trend is particularly important for pediatric patients and/or patients with atypical limb structures and/or needs. Globally, personalized and customized solutions are becoming more accessible, both through cost reductions and greater dissemination of digital manufacturing, allowing patients who were only able to obtain them in high-income countries access and availability to them in lower- to middle-income countries.
• Incorporation of Artificial Intelligence (AI): The incorporation of artificial intelligence (AI) and technology into prostheses and orthotics increases responsiveness of prosthesis/orthotics and experience for patient. AI is found in microprocessors in controlled joints or actuators that contain sensors for angle or movement, in which microprocessors are able to utilize these sensors, act in these angles/movements while responding to any terrains or movements of the user in real-time - thus improving balance and fatigue levels. The FDA has pre-leased approved, AI-enabled prosthetic devices, and this does indicate further confidence in understanding your regulation. The benefits of AI are also found in predictive maintenance, monitoring, and patient safety. AI will allow predictive maintenance and monitoring of devices (being able to inform users of deterioration in adhesion for example) and to ultimately increase device reliability. The continual use of tele-rehabilitation services noted during rapid growth during the COVID-19 pandemic will only improve access to care, further supporting robotic and AI and technology incorporation to prosthetics and orthotics.
• Expansion in Emerging Markets: Emerging economies such as India, Brazil, and African nations are experiencing rising demand for prosthetic and orthotic devices due to improving healthcare infrastructure and increased government support. According to the World Bank, healthcare spending in these regions has grown by over 5% annually since 2020, facilitating better access to rehabilitation technologies. National policies increasingly emphasize disability care and support for assistive devices, often supported by NGOs and international organizations like WHO. Local manufacturing initiatives and cost-reduction strategies are helping overcome affordability barriers, enabling these markets to grow rapidly despite existing healthcare challenges.

Prosthetics and Orthotics Market Dynamics

Market Drivers

• Customization and Personalization: With advances in 3D scanning and printing technologies, personalization of prosthetic and orthotic devices is quickly becoming standard practice. Customized prosthetics and orthotics provide improved fit and comfort, resulting in improved patient compliance and patient outcomes. Regulatory agencies like the FDA provide a framework for addressing the safety and effectiveness of personalized medical devices, and promote much-needed innovation in this space. This trend of customization is particularly critical for children and patients with atypical limb configurations. Personalized solutions are becoming available to patients around the globe as costs decrease and innovation in design and digital manufacturing expands, allowing patients in many low- and middle-income countries access to personalized devices that are typically only available in high-income countries.
• Integration of Artificial Intelligence (AI): The integration of AI into the spectrum of prosthetics and orthotics opens up new levels of responsiveness and user experience in the devices. The incorporation of AI-powered microprocessor-controlled joints, sensors and smart materials also better allows devices to accommodate changes in user movement and the surrounding terrain in real-time while improving balance and reducing fatigue. The FDA's recent approvals of AI-enabled prosthetic devices further validate an increasing level of confidence from regulatory authorities about the integration of AI into these devices. In addition, AI opens up possibilities for predictive maintenance and remote monitoring, improving device reliability, patient safety and accessibility. This trend is also supported by the rapid increase in tele-rehabilitation services for amputees and patients requiring orthoses, which exploded as a result of COVID-19 and continues to expand services using new technologies.
• Growing Awareness and Acceptance: The rising public awareness of disabilities and assistive technologies are expected to have a favorable impact on market demand. Furthermore, advocacy conducted by collective organizations mobilized by the WHO and the International Society for Prosthetics and Orthotics has contributed to lessening stigma and promoting acceptance of prosthetic and orthotic devices. Educational campaigns and changing media representation normalize device use and promote seeked for solutions to a physical problem. Policy revisals by many countries provide greater access to assistive devices than previously and along with social acceptance outlays greater market capacity. Collectively speaking, an increase in market demand and exceptional user support for prosthetic and orthotic users is seen by this cultural shift, alongside individual user satisfaction.

Market Restraints

• High Costs:  Significant costs related to advanced technology and high-quality materials in current prosthetic and orthotic device form worldwide limits access to people requiring prosthesis and/or orthosis, particularly in low- and middle-income countries. Worldwide, it’s estimated the average basic prosthetic limb costs 10's of thousands of dollars and sometimes beyond the reach of uninsured patients. Limited insurance and reimbursement policies related to orthotics and prosthetics make the situation even more complex. Taking the economic factors into consideration, the existing costs will delay time to treatment, prolong disability, and prevent market penetration. Governments and NGOs are trying to address affordability, but cost is still the main limitation/dimension in preventing further market penetration.
• Limited Access to Healthcare Services: Despite marked efforts around the world in developing areas to address the gap in traditional prosthetics and orthotics support and healthcare services, we continue to see many of these services limited by the number of trained prosthetist and orthotists available, or not supported by healthcare systems or infrastructures. According to the WHO only 5-15% of people have access to adequate assistive devices around the world. People in lower-middle developing regions have poor access and affordability to adequate care and treatment precludes appropriate and timely fitting of prosthetics and orthotics, follow-up care and rehabilitation. The scope of gap only further limits rates of adoption of new devices and expansion of the addressable market. The ideal solution of training professionals and enhancing healthcare access is in progress, however, both initiatives require a substantial amount of money and time.
• Regulatory challenges: The prosthetics and orthotics industry must navigate complicated and varied regulatory requirements in different nations. These regulations can complicate the introduction and uptake of new innovative devices. Approval processes for new technologies (especially those environments involving AI-enabled prosthetics) typically include lengthy clinical evaluations and a myriad of different safety standards globally. These regulations add extra development costs and time to market, making companies hesitant to pursue innovation; inconsistent standards across regions create problems for manufacturers trying to achieve global distribution. Harmonizing these regulations and developing syncs with approval pathways is required, but presents challenges.

Market Opportunities

• Technological advancements: New technologies like bionic limbs and wearable exoskeletal devices create exciting possibilities for the prosthetics and orthotics market, allowing individuals improved mobility and function so that they can do more complicated tasks or be active in ways that were once impossible. The U.S. Department of Veterans Affairs (VA) invested, and continues to invest, a substantial amount of money into researching exoskeletal devices to help injured soldiers, showing the level of support from governments. The further development of these technologies and reduced costs may change rehabilitation in an entirely different way and expand who gets access and with that comes training and significant market opportunity.
• Growth in Emerging Markets: Emerging markets also provide a significant growth opportunity for prosthetics and orthotics suppliers as the improvement of the health care infrastructure is in direct response to the new hope disability providers have to offer due to local manufacturing sites, government initiatives, and improved access. In India, for instance, the National Program for Persons with Disabilities has established a model for the distribution of assistive devices. The many people living in these areas, particularly as urbanization intensifies and incomes rises, are generating demand for care and products. Therefore huge market growth opportunities exist, as much of accessibility is not developed and products built on function and price will be attractive to these users.
• Increase in Pediatric Prosthetics: The demand for pediatric prosthetic and orthotic devices is on the rise, as better identification and management of congenital limb differences and acquired injuries in youth is resulting in a need for devices. Early intervention will provide better long-term mobility outcomes, as parents and healthcare professionals seek better and more advanced options. Programs like the U.S. Children’s Health Insurance Program (CHIP) are increasing accessibility and affordability. Lightweight, adjustable, and growth accommodating devices that are specifically designed for pediatric needs are going to spur a market segment with many opportunities to expand.

Market Challenges

• Limited Availability of Skilled Practitioners: Another significant barrier to the prosthetics and orthotics market remains that there are insufficient trained clinicians and technicians to appropriately fit, adjust and maintain prosthetic devices. The World Health Organization indicates that the world is facing a shortage of prosthetics/orthotics professionals globally, particularly in low-income countries. Where there are not enough trained professionals, patients may be fitted poorly and then experience discomfort, limited function, treatment drop-out or abandonment. Although many different types of education and training and certification are becoming available, it remains difficult to address the bottleneck to expand the labour force. This bottleneck limited market growth and delivery or a high level of cranial, prosthetic care.
• Complexity of Technology Integration: The technical and regulatory obstacles to incorporating advanced technologies, such as AI, sensors, and connectivity, into prosthetic and orthotic devices can be daunting. Devices must be designed for functionality, while being mindful of battery and charging issues, durability, and ease of use for the patient. Furthermore, regulations are required for patient safety and to properly provide treatment of patient data. In addition, the complexity of so many different software-hardware phenotypes requires rigorous testing in addition to medical device regulations for patient safety that often leads to delays to come to market. As a result, these technological factors can further increase development costs and complicate the manufacturing processes of prototypes and devices, limiting the climate for innovation and adoption of new devices - particularly in price- sensitive markets.
• Societal and Psychological Barriers: Despite technological advances, social stigma and psychological resistance remain obstacles to prosthetic adoption. Cultural views of disability can discourage individuals from utilizing or seeking prosthetic devices, particularly in certain areas. Mental health support and counseling is often limited (if at all), though it is an essential part of patient acceptance of their situation and rehabilitation. Awareness-raising initiatives and inclusive policies are working to reduce these barriers. However, changing societal views and attitudes would be more long-term progress. Addressing these factors is critical to increase the uptake of devices and the industry, and it is important to recognize that reducing stigma is a long road ahead.

Prosthetics and Orthotics Market Segmental Analysis

Technology Analysis

Electric-powered Prosthetics: Electric-powered prosthetics, also called myoelectric limbs, identify muscle signals through sensors to turn them into motorized movement, vastly benefiting function because you can reconcile activities of daily life far, far better than without it. In 2024, the FDA approved BionicM's motorized knee system for use in the U.S.A. This marks a movement away from traditional prosthetics, to a growing approval of robotic prosthetics. By seamlessly providing motion onto rough surfaces, and potentially independence, these devices are typically considered desirable. The U.S. Department of Veterans Affairs used these advanced prosthetics in their rehabilitation process. WHO's assistive technology reports have also referred to electric-powered limbs as assistive devices with the singular purpose of improving offer to restore mobility, particularly in high-income environments. Public/private investments will be a driver of innovation; to date, DARPA's investment in an AI-powdered limb is still shown on its website. In part to embedded AI and intuitive control mechanisms, these types of technologies are accruing interest around the world, especially in the services of assisting mobility.

Conventional Prosthetics: Conventional prosthetics remain widely used due to affordability, durability, and simplicity, especially in low-resource settings. According to reports from WHO in 2024, most people in lower-income countries who use prosthetics have conventional designs fitted with metal rods, rubber or wood. It provides basic function without powered components, yet it is still essential to mobility. Recently, WHO and ISPO released guidelines on local production and distribution protocols to ensure a better pathway to achieving these products through local workshops. Technology changes in 3D-printing enabled them to reduce manufacturing costs with less compromise to customization. Countries such as Bangladesh and Kenya have found the means to distribute government subsidized conventional prosthetics throughout public health missions. These devices should still be able to provide the necessary support to people with disabilities as part of inclusive and accessible healthcare systems.

Hybrid Orthopedic Prosthetics: Hybrid prosthetics combine mechanical structures with select powered or sensor-driven elements, aiming to balance functionality and cost. They typically offer powered knees or wrists with passive feet or sockets, making them appealing to middle-income regions. In 2023, hybrid knee-ankle systems were introduced in pilot projects funded by the WHO in Southeast Asia and Eastern Europe. Clinical trials in public hospitals showed improved gait and balance when using hybrid systems. The FDA has recognized hybrid designs under emerging tech frameworks for partial automation. Their modular nature allows upgrades over time, which is attractive for patients with evolving physical needs. These devices represent a middle ground between cost-effective conventional limbs and high-tech electric systems.

Type Analysis

Orthotic Devices: Orthotics, such as a brace or a support structure, help to stabilize or correct that deformity of the musculoskeletal, and is particularly important in recovery from traumatic injuries and in chronic conditions like scoliosis. According to WHO’s 2024 data, one-third of the global population could benefit from rehabilitation interventions like orthotics. Assistive devices can also be extremely valuable for patients with congenital disabilities, or with acquired disabilities from strokes or spinal injuries. Countries with national health care plans in Africa and Asia that were supported by WHO have recently begun to include coverage for orthotics for low income populations. Furthermore, there have been advances such as 3D-printed orthoses that shorten time to produce and lower cost, while allowing for a number of customizations. In Uzbekistan, WHO supported orthotic programming has included government structural or funded facilities for more accessible pediatric services for orthotics. These products are among the core health products identified by global health governance.

Prosthetics and Orthotics Market Revenue Share, By Type, 2024 (%)

Prosthetic Devices: Prosthetic limbs are designed to restore mobility in those who have experienced trauma, disease, or defects causing loss of limb(s). While prosthetic limbs can range from simple designs to state-of-the-art devices, the most widely available are basic to mid-level limb prosthetics. In 2023, DEKA's LUKE Arm was approved by the FDA, which lets users perform multiple joint movements with enhanced dexterity.  The World Health Organization (WHO) has promoted prosthetic devices as a human rights issue that must be considered under the approach to universal health coverage. Pilot programs targeted at rural communities have been funded by WHO and local governments in several Southeast Asian countries to expand access to prosthetic care. U.S. veterans' hospitals indicated a 35% improvement in quality-of-life measures with next-gen devices compared to standard fittings. Modular, appropriate technology solutions, or low-cost building block designs for amputees are gaining use in many developing countries and low- and middle-income nations. Growing prosthetic devices are incorporating artificial intelligence, adaptive control, and lighter-weight materials.

End User Analysis

Prosthetic Clinics: Prosthetic clinics are the main entry, or access point for, prosthetic device fitting, adjustment, and patient-training. Many clinics make up a significant portion of prosthetic device sales, and are crucial in getting new technologies like AI-enabled limbs or robotic limbs into the hands of customers. Many clinics in the U.S. have added FDA-cleared electric-powered systems in discovered in 2023.  and offer advanced mobility solutions. Clinics in developing countries are usually public-private partnerships with the support of WHO, and often deliver prosthetics care under partnership with WHO's assistive technology progam.  Clinics in developing countries often provide training courses for prosthetists, to enhance local availability of services.  New reimbursement models have helped clinics in developing countries in Europe and Asia gain viability and provide better access to care. Clinics will remain essential to the supply of ongoing prosthetic device care, adjustments to prosthetic devices after use, and education to devise users for their continued journey with their devices.

Hospitals: Hospitals play a central role in the prosthetics and orthotics ecosystem, especially in surgical preparation, rehabilitation, and integrated device fitting. Many major hospitals in the U.S. and Europe are incorporating smart prosthetics as part of orthopedic and trauma care. The FDA's approvals like the DEKA arm were clinical trials led by hospitals. The WHO's Rehabilitation 2030 recommended a"hospital committee" to assist with integrating the provision of orthotic and prosthetic services into routine hospital care. Following the WHO support and recommendation, hospitals in south-east Asia are developing and expanding their prosthetic departments to address growing demand. Hospitals are increasingly taking the lead in a variety of innovations, including AI-powered diagnostics for limbs, as well as using pressure-mapping technology to improve accurate lens fittings.  Hospitals are critical to both high-tech and community-based prosthetic solutions.

• Rehabilitation Centres: Rehabilitation centres are essential in helping patients adjust to and effectively use prosthetic and orthotic devices after surgery or trauma. These facilities focus on physical therapy, gait training, and psychological support. WHO’s 2024 Southeast Asia regional report noted that over 590 million people need rehabilitation, including prosthetics and orthotics. Recent programs in Uzbekistan and Sri Lanka expanded rehab services with prosthetic support funded by WHO and UNICEF. Centres also play a leading role in training patients to use newer technologies like robotic knees or smart foot sensors. Remote rehabilitation technologies, including wearable monitors, are being trialed in such facilities for follow-up care. Rehabilitation centres bridge the gap between medical intervention and long-term functionality.

Prosthetics and Orthotics Market Regional Analysis

The prosthetics and orthotics market is segmented into several key regions: North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa). Here’s an in-depth look at each region

Why is North America leading the prosthetics and orthotics market?

• The North America prosthetics and orthotics market size was valued at USD 2.64 billion in 2024 and is forecasted to reach around USD 4.03 billion by 2034.

North America is led by the U.S. in advanced prosthetic technologies; in 2024, the FDA approved additional prosthetics with AI-enabled/robotic features - BionicM’s motorized knee and the DEKA LUKE Arm - along with strong regulatory approval/popularity. Canadian provincial governments fund prosthetics through government policies, referring to plans in provinces such as Ontario, which funds microprocessor knees (~USD 15,000) for eligible clients and Saskatchewan which covers similar plans and the recent Canada Disability Benefit legislation of USD 6.1 B over six years for assistive technology in 2024 funding. Mexico's path for regulating prosthetic devices includes COFEPRIS and standards for NOM devices, ensuring these prosthetic devices are safe for consumers, government generated safety protocols and can rely on the national quality infrastructure, all of which also help provide consumer protection. In summary, across North America, sources of public funding, developing regulations around prosthetic and orthotic devices and disability benefit plans are all seeds of improvement of accessing prosthetic and orthotic care.

What are the driving factors of Europe prosthetics and orthotics market?

• The Europe prosthetics and orthotics market size was estimated at USD 1.42 billion in 2024 and is expected to hit around USD 2.16 billion by 2034.

In Europe, the UK has budgeted USD 0.017 B (2023-24) into 17 prosthetic/orthotic R&D's through NIHR and UKRI via the National Health Service, including smart limbs and AR sensory tools for patients; NHS England now pays for (the manufacturer provides) bionic arms with natural grip for eligible patients. We assume Germany will or is still funding or supporting same research for their continued reliance on sensor orthotic and digital rehabilitation as prosthetics and orthotics that remain under the provision of care under federal healthcare standards and guidelines. France’s national health authority (HAS) has expanded coverage for advanced orthotic devices in 2023, ensuring broader access under universal health coverage. EU-wide regulations harmonize safety standards for smart prostheses and AI medical devices, supported by public hospital rollout of next-gen limbs. These coordinated initiatives reflect strong state commitment to innovation and equitable service delivery across Europe.

Prosthetics and Orthotics Market Revenue Share, By Region, 2024 (%)

Why is the Asia-Pacific region witnessing rapid growth in the prosthetics and orthotics market?

• The Asia-Pacific prosthetics and orthotics market size was recorded at USD 1.81 billion in 2024 and is estimated to surpass around USD 2.75 billion by 2034.

In Asia-Pacific, China’s National Health Commission in 2024 issued directives to bolster prosthetic clinics equipped with smart diagnostic tools in rural and urban centers. India’s Ministry of Social Justice supports institutes like SVNIRTAR in Odisha (~900 students) to train orthotists and expand AI-based socket use; local manufacturing and NGO collaborations are growing. Japan’s Ministry of Health continues to fund research into lightweight carbon-fiber limbs, while Australia’s Department of Health reformed the Prostheses List in 2023–25, reducing private health gaps and allocating USD 0.014 billion for list modernization. South Korea’s KIMM unveiled an AI-based adaptive prosthetic socket in 2023, responsive to residual limb volume changes in real time via smartphone integration. These developments underscore APAC’s blend of regulation, training, and innovation across countries.

What are the trends of the LAMEA prosthetics and orthotics market?

• The LAMEA prosthetics and orthotics market size was valued at USD 0.58 billion in 2024 and is poised to reach around USD 0.88 billion by 2034.

In LAMEA, Brazil’s SUS health system (USD 7.3 billion budget, ~100% population coverage) provides free dental prosthetics and is expanding limb prosthesis through specialized centers, recovering from pandemic delays. The UAE’s Ministry of Health has included prosthetic services in national disability policy since 2023, enhancing access to robotic limbs in Abu Dhabi hospitals. Saudi Arabia’s Vision 2030 targets expanded rehabilitation and prosthetic centers, with pilot exoskeleton programs reported in Riyadh in 2024. South Africa’s provincial health departments, including Eastern Cape, partnered with universities like Walter Sisulu to provide pediatric prosthetic legs in 2024, improving rural access. UAE and Saudi regulatory agencies (e.g., SFDA) are working to harmonize standardization with international norms to ensure safety and quality.

Prosthetics and Orthotics Market Top Companies

• Ossur
• Blatchford Limited
• Fillauer LLC
• Bauerfeind
• Aether Biomedical
• Mobius Bionics
• Ultraflex Systems Inc.
• Steeper Group
• Ottobock
• WillowWood Global LLC.
• Hanger, Inc.

Recent Developments

Recent partnerships in the prosthetics and orthotics industry emphasize innovation, rehabilitation access, and smart device integration. In 2023, Össur partnered with the Alfred Mann Foundation to accelerate neuro-controlled prosthetic limb research using implanted myoelectric sensors. Blatchford collaborated with the UK NHS to expand access to energy-efficient microprocessor knees for post-amputation patients. Aether Biomedical teamed up with Polish rehabilitation hospitals to trial AI-powered bionic hand technology under clinical supervision. Fillauer LLC signed an agreement with Liberating Technologies, Inc. to co-develop upper-limb prosthetics using multi-electrode signal processing. Meanwhile, Bauerfeind worked with German sports medicine institutes to refine dynamic orthoses for injury prevention. These alliances highlight the industry’s commitment to merging clinical care with biomechatronics and adaptive technologies.

• In February 2024, Össur has announced plans to establish a new parent organization named Embla Medical, which will become the listed company and reflect the company’s evolution into a global provider of mobility solutions for people with chronic mobility challenges. The change, subject to approval at the March 2024 Annual General Meeting, will see Össur hf. renamed Embla Medical hf., while all existing product and patient care brands—such as Össur, College Park, and FIOR & GENTZ—will continue operating as usual. The new name, inspired by Norse mythology, symbolizes new beginnings and movement, and aims to unify the company’s diverse brands under a shared purpose without affecting customer relationships or service.
• In May 2025, Blatchford, a leading global manufacturer of advanced prosthetic and orthotic technologies, announced a USD 0.0170 billion investment in a new, state-of-the-art Operations Centre of Excellence in Basingstoke, UK. The 70,000 sq. ft. facility, set to be fully operational by the end of the year, will double Blatchford’s operational footprint and bring together manufacturing, assembly, and distribution teams under one roof for the first time. The centre is designed to boost efficiency, increase machining capacity by 50%, and improve production efficiency by 30%, focusing exclusively on prosthetics. It also features modern amenities for staff and is built to high environmental standards, supporting Blatchford’s goal to achieve net zero emissions ahead of the UK government’s 2050 target. This investment reflects Blatchford’s commitment to innovation, sustainability, and meeting growing global demand for its life-changing mobility solutions.

Market Segmentation

By Technology 

• Electric-powered
• Conventional
• Hybrid Orthopaedic Prosthetics

By Type

• Orthotics
  • Upper limb
  • Lower limb
  • Spinal
• Prosthetics
  
  • Upper Extremity
  • Lower Extremity
  • Liners
  • Sockets
  • Modular Components

By End-User

• Prosthetics Clinics
• Hospitals
• Rehabilitation Centre

By Region

• North America
• APAC
• Europe
• LAMEA